Catalyst
Slingshot members are tracking this event:
AnaptysBio's (ANAB) Etokimab ATLAS Phase 2b Clinical Trial in Moderate-to-Severe Atopic Dermatitis Data Released
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 08, 2019
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Etokimab, Atlas, Phase 2b, Atopic Dermatitis, Phase 2b Eclipse Trial
